Novavax (NVAX) Misses Q4 EPS by 1c

Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $7.09 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15